Patienter med allerede kendt leverdysfunktion, inklusiv kronisk aktiv hepatitis har en øget risiko for leverfunktionsabnormaliteter ved antiretroviral kombinationsterapi og bør monitoreres i henhold til standard praksis.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.